What is Airway Medix S.A.'s (AWM.WA) StockRank?

MoatMap's StockRank for Airway Medix S.A. (AWM.WA) is 8/100, with a Strong Sell signal. This is a composite score combining Quality (16), Value (34), and Momentum (29) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Airway Medix S.A. have an economic moat?

Airway Medix S.A. (AWM.WA) has a Quality factor score of 16/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Airway Medix S.A. a buy, hold, or sell?

MoatMap's current signal for Airway Medix S.A. (AWM.WA) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Airway Medix S.A. in?

Airway Medix S.A. (AWM.WA) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Poland).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

AWM.WA

Strong SellSinker

Airway Medix S.A. · Healthcare · Poland · $7M · Avg Vol: $7K/d

StockRank

Get insider-trade alerts

P/E (TTM)

13.3x

ROE

—

D/E

—

Dividend %

—

COMPANY DESCRIPTION

Airway Medix S.A. is a Polish medical device company focused on the development and commercialization of innovative, patented products for patients in intensive care units (ICUs). The company's proprietary technologies are designed to automate airway clearance and prevent ventilator-associated pneumonia (VAP), addressing critical clinical challenges in mechanical ventilation. It operates an R&D-heavy, asset-light business model, aiming to license its intellectual property to major global medical device distributors.

FINANCIAL SUMMARY (PLN)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	95.0K	12.0K	12.0K	4.0K	-65.2%	89.0K
EPS (PLN)	-0.65	-0.05	-0.16	0.02	—	0.02
Shares	58.4M	61.1M	73.7M	101.5M	+73.7%	96.6M
Debt	14.6M	14.5M	21.9M	12.9M	-4.1%	13.6M
Equity	-15.2M	-13.2M	-24.3M	-8.5M	—	—
Op CF	-0.4M	-4.2M	-7.6M	-3.4M	—	-1.0M
Inv CF	-0.1M	0	-72.0K	-0.2M	—	—
Fin CF	0.6M	4.8M	9.1M	1.6M	—	—

Loading 1Y...

PRICE (1Y)-1.7%

SMA 50SMA 200

$0.0708

RSI (14)

44.6

52W High

$0.1185

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC (ROA)

-56.1%*14.2

ROE

—N/A

GP/Assets

-0.3%8.7

Op. Margin

-1005.9%7.2

FCF/Assets

-29.5%14.1

Piotroski

316.1

Int. Cover

2.1x42.5

D/E Ratio

—N/A

Current Ratio

0.07x0.3

Value

P/E (TTM)

13.3x79.6

EV/EBITDA

-6.8x25.0

P/FCF

—N/A

P/B

-3.0x25.0

P/S

288.6x4.3

Div Yield

—N/A

Momentum

52W High %

60%35.5

RS 6M

-36%22.9

SMA 50/200

0.91x33.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$7M

P/E (Forward)

—

Gross Margin

—

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AWM.WA are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
AWM.WA	Airway Medix S.A.(you)	$7M	8	Strong Sell
PUR.WA	Pure Biologics S.A.	$8M	3	Strong Sell
MQR.WA	MultiQure S.A.	$10M	3	Strong Sell
URT.WA	Urteste S.A.	$18M	12	Strong Sell
GMT.WA	Genomtec S.A.	$17M	1	Strong Sell
MRC.WA	Mercator Medical S.A.	$143M	73	Buy
MAB.WA	Mabion S.A.	$34M	10	Strong Sell
NNG.WA	NanoGroup S.A.	$28M	14	Strong Sell
PTG.WA	Poltreg S.A.	$34M	13	Strong Sell
MOC.WA	Molecure S.A.	$40M	14	Strong Sell

Peer medians: ROE -17.6% · P/E 18.1x · Gross margin 30.3%

Price	$0.07
Market Cap	$7M
P/E (TTM)	13.30
Price/Book	-3.02
Operating Margin	-1005.9%
Free Cash Flow	$-975K

Company Deep Dive

AWM.WA

COMPANY DESCRIPTION

FINANCIAL SUMMARY (PLN)

SCORE BREAKDOWN

FUNDAMENTALS

SECTOR PEERS

Airway Medix S.A. (AWM.WA): Stock Score Summary

Key Financial Metrics

Frequently Asked Questions